DL. Millis, JP. Weigel; T. Moyers; FC. Buonomo, Effect of deracoxib, a new COX-2 inhibitor, on the prevention of lameness induced by chemical synovitis in dogs., in Vet Ther, vol. 3, n. 4, 2002, pp. 453-64, PMID12584683.
KA. Sennello, MS. Leib, Effects of deracoxib or buffered aspirin on the gastric mucosa of healthy dogs., in J Vet Intern Med, vol. 20, n. 6, pp. 1291-6, PMID17186840.
AD. Gassel, KM. Tobias; SK. Cox, Disposition of deracoxib in cats after oral administration., in J Am Anim Hosp Assoc, vol. 42, n. 3, pp. 212-7, PMID16611933.
JK. Sessions, LR. Reynolds; SC. Budsberg, In vivo effects of carprofen, deracoxib, and etodolac on prostanoid production in blood, gastric mucosa, and synovial fluid in dogs with chronic osteoarthritis., in Am J Vet Res, vol. 66, n. 5, maggio 2005, pp. 812-7, PMID15934608.